Pelvic closure capsule and preparation method thereof

Abstract

The invention belongs to the field of medicaments, particularly relates to a pelvic closure capsule and a preparation method thereof, and aims to solve the problem of poor effect in the prior art. According to the technical scheme, the pelvic closure capsule comprises a capsule shell and a medicament, wherein the medicament is prepared from 5 to 8 parts of a mangosteen extract, 2 to 4 parts of herba asari, 3 to 6 parts of water lily, 1 to 2 parts of rhizoma chuanxiong, 1 to 2 parts of rhizoma gastrodiae, 3 to 6 parts of flos carthami, 5 to 9 parts of borneol, 5 to 8 parts of radix ginseng, 15 to 20 parts of a microwave extracting solution, 25 to 30 parts of a water boiling fermentation extracting solution and 15 to 20 parts of an auxiliary extract. According to the invention, the pelvic closure capsule has the effects of tightening pelvic bones, avoiding pelvic bone looseness, tightening rectus abdominis, tightening birth canals, restoring elasticity of pelvic floor muscles, diminishing inflammation, inhibiting bacteria, raising pubis, bulging fibrous tissues, upwarping buttocks, make pubic symphysis full and plump, warming uterus, restoring female pelvic cavity rejuvenation, enhancing the immunity of a reproductive system, increasing uterus and ovarian functions and delaying climacteric.

Description

technical field [0001] The invention relates to the technical field of medicaments, in particular to a pelvic closure capsule and a preparation method thereof. Background technique [0002] The patent application number CN201380058460.3 discloses a bicyclic urea, thiourea, guanidine and cyanoguanidine compounds that can be used to treat pain. The present invention discloses a compound of formula I: or its stereoisomers, tautomers or a pharmaceutically acceptable salt, solvate or prodrug, wherein ring A, ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases that can be treated with TrkA kinase inhibitors, such as pain , cancer, inflammation / inflammatory disease, neurodegenerative disease, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis, and pelvic pain syndrome. [0003] But the dicyclic urea, thiourea, guanidine and cyanoguanidine compounds that can be used to...

AI Technical Summary

Problems solved by technology

[0004] Based on the problems of poor therapeutic effect and single function in the background technology, the present invention proposes a pelvic closure capsule and a preparation method thereof

Images